EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 75 filers reported holding EDITAS MEDICINE INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $503 | -60.9% | 64,500 | -58.7% | 0.00% | -50.0% |
Q2 2023 | $1,286 | -100.0% | 156,300 | -82.7% | 0.00% | -90.0% |
Q1 2022 | $17,183,000 | +183.7% | 903,400 | +296.1% | 0.02% | +150.0% |
Q4 2021 | $6,056,000 | -23.6% | 228,100 | +62.9% | 0.01% | -20.0% |
Q2 2021 | $7,930,000 | -58.6% | 140,000 | -69.3% | 0.01% | -58.3% |
Q1 2021 | $19,149,000 | +543.2% | 455,927 | +329.7% | 0.02% | +700.0% |
Q3 2020 | $2,977,000 | -49.7% | 106,100 | -47.0% | 0.00% | -40.0% |
Q2 2020 | $5,919,000 | -0.8% | 200,100 | -33.5% | 0.01% | -16.7% |
Q1 2020 | $5,967,000 | +145.5% | 300,900 | +266.5% | 0.01% | +200.0% |
Q4 2019 | $2,431,000 | -73.2% | 82,100 | -77.9% | 0.00% | -75.0% |
Q1 2019 | $9,081,000 | +46.8% | 371,400 | +36.5% | 0.01% | +14.3% |
Q4 2018 | $6,188,000 | -35.2% | 272,000 | -9.4% | 0.01% | -30.0% |
Q3 2018 | $9,549,000 | +451.6% | 300,100 | +133.7% | 0.01% | +233.3% |
Q3 2016 | $1,731,000 | +218.2% | 128,400 | +475.7% | 0.00% | +200.0% |
Q2 2016 | $544,000 | – | 22,304 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |